OMC
NEPH icon

Overbrook Management Corp’s Nephros NEPH Stock Holding History

Overbrook Management Corp’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-91,145
Closed -$659K – 110
2020
Q3 		$659K Sell
91,145
-39,195
-30% -$287K 0.15% 74
2020
Q2 		$1.09M Buy
+130,340
New +$1.03M 0.29% 60

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Overbrook Management Corp's NEPH Position: Q4 2020 in Review

Overbrook Management Corp sold out of Nephros (NEPH) in Q4 2020, closing a stake of 91,145 shares — an estimated $659K sold.

Overbrook Management Corp first reported a position in NEPH in Q2 2020 and held it in 2 quarters. The position peaked at $1.09M in Q2 2020. 16 funds tracked by Wall St. Rank hold NEPH as of Q4 2020.

  • Overbrook Management Corp reported no remaining Nephros position as of Q4 2020 after selling out during the quarter.
  • Overbrook Management Corp sold 91,145 Nephros shares in Q4 2020, an estimated $659K.
  • Overbrook Management Corp first reported a position in Nephros in Q2 2020 and held it in 2 quarters.
  • Overbrook Management Corp's Nephros position peaked at $1.09M in Q2 2020.
  • 16 funds tracked by Wall St. Rank held Nephros as of Q4 2020.

Based on Overbrook Management Corp's 13F filing for Q4 2020, filed 16 Feb 2021.